ASTRO 2022 abstracts featured notable research findings for use of radiotherapy in diseases such as early-stage breast cancer, orbital indolent B-cell lymphoma, and locally advanced cervical cancer.
Higher-dose Stereotactic Radiotherapy Achieves Better Control for Many Aggressive Lung Tumors
Research examines the role of higher-dose radiation and fewer sessions for patients with aggressive lung cancer
Designing an Optimal Breast Cancer Radiation Protocol
A radiation oncologist and surgeon discuss how partial breast irradiation, novel tissue markers and deep inspiratory breath holds fit into Cleveland Clinic’s breast cancer radiation protocols.
Is Brachytherapy for Brain Tumors Back? Expert Perspectives on GammaTile
GammaTile brachytherapy is among the newest additions to the brain tumor armamentarium. Two of our neuro-oncology experts size up its place in therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Researchers Identify Genetic Basis for Cancer Cells’ Susceptibility to DNA Damage
Cancer cells’ sensitivity to ionizing radiation results from significant underlying biological diversity within and across lineages, reports a research team that has identified a variety of genetic determinants that enable cancer cells to survive radiation exposure. The findings may make it possible to tailor radiation treatments to exploit the genetic alterations present in a patient’s tumor.